Abstract

Introduction/BackgroundHRD identifies HGOC patients most likely to benefit from PARPi. Unlike commercially available genomic-scar HRD tests(CT), functional testing by RAD51, has potential to provide real-time readout of current HR status...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Distribution of homologous recombination deficiency (HRD) and BRCA mutations (m) detected by HRD-One test among Brazilian patients (pts) with newly diagnosed advanced epithelial ovarian, fallopian tube, or peritoneal cancer.
Mariana Scaranti ... Rodrigo Guarischi Sousa
Journal of Clinical Oncology | VOL. 40
Mariana Scaranti, et. al.Mariana Scaranti ... Rodrigo Guarischi Sousa
01 Jun 2022
Correlation of BRCA and HRD status with clinical and survival outcomes in patients with advanced-stage ovarian cancer in the age of PARPi maintenance therapy (187)
Travis Sims ... Nicole Fleming
Gynecologic oncology | VOL. 166
Travis Sims, et. al.Travis Sims ... Nicole Fleming
01 Aug 2022
#889 Effect of BRCA or HRD status on the efficacy of hyperthermic intraperitoneal chemotherapy in advanced epithelial ovarian cancer
Upasana Palo ... Jaydip Bhaumik
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. 33
Upasana Palo, et. al.Upasana Palo ... Jaydip Bhaumik
01 Sep 2023
Progression-free survival (PFS) and second PFS (PFS2) by disease stage in patients (pts) with homologous recombination deficiency (HRD)-positive newly diagnosed advanced ovarian cancer receiving bevacizumab (bev) with olaparib/placebo maintenance in the phase III PAOLA-1/ENGOT-ov25 trial.
Patricia Pautier ...
Journal of Clinical Oncology | VOL. 39
Patricia Pautier, et. al.Patricia Pautier ...
20 May 2021
View more papers

More From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Paper Title
Journal
Date
Author
Secondary databases in gynecologic cancer research
Katherine Hicks-Courant ... Pedro T Ramirez
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Katherine Hicks-Courant, et. al.Katherine Hicks-Courant ... Pedro T Ramirez
23 Jul 2024
Cervical cancer and risk of dementia: real-world insights from a nationwide cohort study in Taiwan
Siou-Ting Lee ... Nian-Sheng Tzeng
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Siou-Ting Lee, et. al.Siou-Ting Lee ... Nian-Sheng Tzeng
23 Jul 2024
DNA methylation detection is a significant biomarker for screening endometrial cancer in premenopausal women with abnormal uterine bleeding
Xingping Zhao ... Dabao Xu
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Xingping Zhao, et. al.Xingping Zhao ... Dabao Xu
23 Jul 2024
Best original research presented at the 25th European Congress on Gynaecological Oncology: best of ESGO 2024
Joanna Kacperczyk-Bartnik ... Domenica Lorusso
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | VOL. -
Joanna Kacperczyk-Bartnik, et. al.Joanna Kacperczyk-Bartnik ... Domenica Lorusso
20 Jul 2024
View more papers